Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beclomethasone/Formoterol HFA pMDI in Mild to Moderate Asthma
NCT00862264Phase 3Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Aug 2004
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of beclomethasone dipropionate, formoterol in asthma, sponsored by Chiesi Farmaceutici S.p.A.. Started Aug 2004; status: completed.
02
Drugs
beclomethasone dipropionateformoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00862264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00862264.